Loading clinical trials...
Loading clinical trials...
The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients.
The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients. * A prospective observational cohort study will be performed in our burn ICU at Ain Shams University Hospitals. Ethical clearance will be taken from the institutional ethics committee. Written informed consent will be obtained from the patients/authorized representatives of the patients. * All eligible pediatric patients with severe burns will be enrolled within 24 hours of admission after obtaining informed consent. * Minimum sample needed for statistical significance was calculated a priori and found to be (60). * After consent, Patients' characteristics (age, sex, etc….), clinical parameters (TBSA, Abbreviated Burn Severity Index \[ABSI\], presence of inhalational injury), and comorbidities will be recorded. * Complete blood count (CBC) will be done upon admission and will be repeated on days 1, 3, 5 and 7. * Total leucocyte count (TLC), differential leucocyte count (DLC) and platelet count (PC) will be reported as part of the CBC results. NLR and PLR will be calculated as per the following: NLR: ratio of absolute neutrophil count to absolute lymphocyte count. PLR: ratio of platelet counts to absolute lymphocyte count. * Data about respiratory status at ICU admission (invasive or non-invasive mechanical ventilation, high-flow oxygen therapy) and progression to endotracheal intubation and invasive mechanical ventilation (IMV), the day of endotracheal intubation and IMV initiation, and duration of ventilation will be recorded. * Patients will be evaluated on days 0,1, 3, 5, 7 of admission for diagnosis of ARDS. * ARDS will be determined using the pediatric ARDS criteria from the Pediatric Acute Lung Injury Consensus Conference. Primary outcome: o To evaluate the predictive value of admission NLR and PLR for development of ARDS within 30 days in pediatric burn patients. Secondary outcomes: * Determine optimal cut-off values (ROC) of NLR and PLR for ARDS prediction. * Compare predictive performance of NLR and PLR with established clinical predictors (TBSA%, inhalation injury, age). * Study the predictive value of the dynamic changes of NLR/PLR for mechanical ventilation need, ventilator days, ICU length of stay, and mortality.
Age
1 - 12 years
Sex
ALL
Healthy Volunteers
No
Ain Shams University
Cairo, Egypt
Start Date
November 10, 2025
Primary Completion Date
May 10, 2027
Completion Date
November 10, 2027
Last Updated
March 2, 2026
60
ESTIMATED participants
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios
DIAGNOSTIC_TEST
Lead Sponsor
Ain Shams University
NCT06701669
NCT07086755
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions